Association of aminopeptidase N and endopeptidase 24.15 inhibitors potentiate behavioral effects mediated by nociceptin/orphanin FQ in mice

FEBS Lett. 1997 Jan 20;401(2-3):227-9. doi: 10.1016/s0014-5793(96)01476-7.

Abstract

The behavioral effects induced by central administration in mice of the endogenous ORL1 (opioid receptor-like1) ligand, nociceptin/orphanin FQ, were investigated in the absence or presence of inhibitors of aminopeptidase N (bestatin) and endopeptidase 24.15 (Z-(L,D)Phe psi(PO2CH2)(L,D)Ala-Arg-Phe) recently shown to be involved in the metabolism of the heptadecapeptide in vitro. A severe reduction in motor activity induced by nociceptin/orphanin FQ was measured in two tests (spontaneous motor activity and open field). This pharmacological effect was shown to be potentiated by the association of bestatin and Z-(L,D)Phe psi(PO2CH2)(L,D)Ala-Arg-Phe, confirming in vivo the involvement of these peptidases in nociceptin/orphanin FQ inactivation. In our conditions, these inhibitors were devoid of intrinsic effects, suggesting a low tonic regulation by the heptadecapeptide of the measured behaviour.

MeSH terms

  • Animals
  • CD13 Antigens / antagonists & inhibitors
  • CD13 Antigens / metabolism*
  • Enzyme Inhibitors / pharmacology*
  • Injections, Intraventricular
  • Leucine / analogs & derivatives
  • Leucine / pharmacology
  • Male
  • Metalloendopeptidases / antagonists & inhibitors
  • Metalloendopeptidases / metabolism*
  • Mice
  • Motor Activity / drug effects*
  • Nociceptin
  • Opioid Peptides / pharmacology*
  • Receptors, Opioid / agonists*

Substances

  • Enzyme Inhibitors
  • Opioid Peptides
  • Receptors, Opioid
  • CD13 Antigens
  • Metalloendopeptidases
  • thimet oligopeptidase
  • Leucine
  • ubenimex